ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cardiovascular disease and rheumatoid arthritis (RA)"

  • Abstract Number: 68 • 2018 ACR/ARHP Annual Meeting

    A Genome-Wide Association Study Identifies rs116199914 As an Intergenic Variant Associated with Carotid Intima-Media Thickness in Spanish Patients with Rheumatoid Arthritis

    Raquel Lopez-Mejías1, Fernanda Genre1, Sara Remuzgo-Martínez1, David Carmona2,3, Verónica Pulito-Cueto1, Carlos González-Juanatey4, Alfonso Corrales1, Esther Vicente5, Jose A. Miranda-Filloy6, Beatriz-Segura Tejera7, Marco A. Ramírez Huaranga8, Verónica Mijares1, Leticia Lera-Gomez1, Ricardo Blanco1, Montserrat Robustillo-Villarino9, Javier Rodríguez-Carrio10, Ana Suárez10, Mercedes Alperi-López11, Francisco Javier Ballina-García12, Francisco Javier López Longo13, Francisco Javier Narváez14, Juan José Alegre9, Antonio Mera15, Eva Perez Pampín16, Antonio Gonzalez17, Enrique Raya Álvarez18, Chary López-Pedrera19, Carmen Gomez Vaquero14, Alejandro Balsa20, Dora Pascual-Salcedo20, Patricia Carreira21, Isidoro Gonzalez-Alvaro5, Luis Rodriguez Rodriguez22, Benjamin Fernandez Gutierrez22, Ivan Ferraz-Amaro23, Santos Castañeda24, Javier Martin3, Javier Llorca25 and Miguel Angel González-Gay1,26,27, 1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, Santander, Spain, 2Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Granada, Spain, 3Instituto de Parasitología y Biomedicina ‘López-Neyra’, CSIC, PTS Granada, Granada, Spain, 4Division of Cardiology, Hospital Universitario Lucus Augusti, Lugo, Spain, 5Rheumatology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 6Rheumatology Department, Hospital Universitario Lucus Augusti, Lugo, Spain, 7Rheumatology Division, Hospital Insular de Gran Canaria, Las Palmas, Spain, 8Rheumatology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, 9Rheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain, 10Area of Immunology, Department of Functional Biology, University of Oviedo, Oviedo, Spain, 11Department of Rheumatology, Hospital Universitario Central de Asturias, Asturias, Spain, 12Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo, Spain, 13Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 14Rheumatology Department, Hospital Universitario de Bellvitge, Idibell, Barcelona, Spain, 15Rheumatology Division. Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain, 16Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain, 17Laboratorio Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain, 18Rheumatology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, 19IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 20Rheumatology Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain, 21Servicio de Reumatología, Hospital Universitario, Madrid, Spain, 22Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain, 23Rheumatology Division, Hospital Insular de Gran Canaria, La Laguna, Spain, 24Rheumatology, Rheumatology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 25School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain, 26School of Medicine, University of Cantabria, Santander, Spain, Santander, Spain, 27Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose: Cardiovascular (CV) disease is the most common cause of morbidity and mortality in patients with rheumatoid arthritis (RA) [1, 2]. Traditional CV risk factors…
  • Abstract Number: 85 • 2018 ACR/ARHP Annual Meeting

    Antibodies to Citrullinated Protein Antigens (ACPAs) Induce Adipose Tissue Dysfunction Contributing to the Cardiovascular Disease Risk in Rheumatoid Arthritis. Modulation By Biological Dmards

    Nuria Barbarroja1, Ivan Arias de la Rosa2, Miriam Ruiz-Ponce3, Maria Dolores de la Rosa-Garrido3, Patricia Ruiz-Limon4, Yolanda Jiménez-Gómez1, Carlos Perez-Sanchez1, Maria Carmen Abalos-Aguilera2, Rocio Guzman-Ruiz5, Maria del Mar Malagon6, Francisco Jose Tinahones7, Eduardo Collantes-Estévez1, Chary Lopez-Pedrera3 and Alejandro Escudero-Contreras2, 1Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 4Research Group of Endocrine Diseases, Research Laboratory. Biomedical Research Institute of Malaga (IBIMA).Virgen de la Victoria Universitary Hospital, Malaga, Spain., Málaga, MA, Spain, 5Department of Cell Biology, Physiology, and Immunology,, IMIBIC/University of Córdoba/Reina Sofía University Hospital, Cordoba, Spain, 6Department of Cell Biology, Physiology, and Immunology,I, IMIBIC/University of Córdoba/Reina Sofía University Hospital, Cordoba, Spain, 7Department of Clinical Endocrinology and Nutrition, Institute of Biomedical Research of Málaga (IBIMA), Hospital of Málaga (Virgen de la Victoria), University of Málaga (UMA), Málaga, Spain; CIBER Fisiopatología Obesidad y Nutrición, Instituto de Salud Ca, Malaga, Spain

    Background/Purpose: 1) To test the relationship among ACPAs and levels of adipocytokines and atherosclerosis in RA patients. 2) To analyze the effects of ACPAs on…
  • Abstract Number: 209 • 2018 ACR/ARHP Annual Meeting

    Development of an Algorithm for the Classification of Cardiovascular Comorbidity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative

    Kangping Cui1,2, Mohammad Movahedi3, Claire Bombardier4 and Bindee Kuriya5, 1Internal Medicine, University of Western Ontario, London, ON, Canada, 2Toronto General Hospital Research Institute, Toronto, ON, Canada, 3JSS Medical Research, St-Laurent, QC, Canada, 4Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 5Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada

    Development of an Algorithm for the Classification of Cardiovascular Comorbidity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research InitiativeBackground/Purpose: Cardiovascular disease (CVD) is…
  • Abstract Number: 510 • 2018 ACR/ARHP Annual Meeting

    Lipid Profile and Cardiovascular Risk in Subjects at Risk for Rheumatoid Arthritis

    Laurette van Boheemen1, Marian van Beers-Tas2, Dirkjan van Schaardenburg3 and Michael Nurmohamed2, 1Rheumatology, Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, Netherlands, 2Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, Netherlands, 3Amsterdam Rheumatology and immunology Center, Reade, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease associated with an increased cardiovascular (CV) risk that is already present at the time of…
  • Abstract Number: 518 • 2018 ACR/ARHP Annual Meeting

    Cardiometabolic Risk Factors Impact on the Cardioprotective Effect of Apelin on Systolic and Diastolic Function, in Patients with Rheumatoid Arthritis

    Sulé Gunter1, Lebogang Mokotedi2, Monica Gomez2, Linda Tsang2, Aletta Millen3 and Patrick Dessein2, 1Depeartment of Health Sciences, School of Physiology, University of the Witwatersrand, Johannesburg, South Africa, 2Department of Health Sciences, School of Physiology, University of the Witwatersrand, Johannesburg, South Africa, 3Department of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose: The rheumatoid arthritis (RA) population demonstrate a significantly increased incidence of cardiac events. Cardiac dysfunction in RA may occur as a result of impaired…
  • Abstract Number: 540 • 2018 ACR/ARHP Annual Meeting

    Echocardiographic Abnormalities in Rheumatoid Arthritis Patients Compared to Age, Sex and Traditional Cardiovascular Risk Factors Matched Controls

    Suad Hannawi1, Kashif Naeem2, Haifa Hannawi3 and Issa Al Salmi4, 1Rheumatology Department. Ministry of Health and Prevention, Asst.Prof, Dubai, United Arab Emirates, 2Cardiology Department. Ministry of Health and Prevention, Dr, Dubai, United Arab Emirates, 3Research Department. Ministry of Health and Prevention, Asst.Prof, Dubai, United Arab Emirates, 4Prof, Muscat, Oman

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease of the joints with several extra-articular features. Cardiovascular disease (CVD) mortality accounts for 40-50% of…
  • Abstract Number: 1521 • 2018 ACR/ARHP Annual Meeting

    Anti-IL-6 Therapy Modulates Leptin in Patients with Rheumatoid Arthritis

    Sara Remuzgo-Martínez1, Fernanda Genre1, Verónica Pulito-Cueto1, Verónica Mijares1, Leticia Lera-Gómez1, Jaime Calvo-Alén2, Ricardo Blanco1, Oreste Gualillo3, Javier Llorca4, Santos Castañeda5, Raquel Lopez-Mejías1 and Miguel Angel González-Gay1,6,7, 1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, Santander, Spain, 2Rheumatology Department, Hospital Universitario Araba. Vitoria-Gasteiz, Alava, Spain, 3SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Santiago University Clinical Hospital, Santiago de Compostela, Spain, Santiago de Compostela, Spain, 4Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain, Santander, Spain, 5Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain, 6Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 7School of Medicine, University of Cantabria, Santander, Spain, Santander, Spain

    Background/Purpose: Leptin is an adipokine that plays an important role in the regulation of body weight and also participates in immune homeostasis and inflammatory processes1,2.…
  • Abstract Number: 2815 • 2018 ACR/ARHP Annual Meeting

    Cardiovascular Safety – Update from up to 6 Years of Treatment with Baricitinib in Rheumatoid Arthritis Clinical Trials

    Michael Weinblatt1, Peter C. Taylor2, Gerd R. Burmester3, Chadi Saifan4, Chad D. Walls4, Maher Issa4, Terence P. Rooney4 and Tsutomu Takeuchi5, 1Brigham and Women’s Hospital, Boston, MA, 2Botnar Research Centre, Univ of Oxford, Oxford, United Kingdom, 3Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, 4Eli Lilly and Company, Indianapolis, IN, 5Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose: Baricitinib (BARI), a selective inhibitor of Janus kinases, is approved in >40 countries for the treatment of active rheumatoid arthritis (RA) in adults. Patients…
  • Abstract Number: 2816 • 2018 ACR/ARHP Annual Meeting

    Development of a Microrna Panel for Predicting Coronary Atherosclerosis in Rheumatoid Arthritis

    Michelle J. Ormseth1, Joseph F. Solus1, Quanhu Sheng1, Fei Ye1, Yan Guo1, Qiong Wu1, Annette M. Oeser1, Ryan Allen1, Paolo Raggi2, Kasey Vickers1 and C Michael Stein1, 1Vanderbilt University Medical Center, Nashville, TN, 2University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Small noncoding RNAs (sRNAs), such as microRNAs (miRNAs), regulate gene expression and can be used as biomarkers of disease. Patients with rheumatoid arthritis (RA)…
  • Abstract Number: 2417 • 2017 ACR/ARHP Annual Meeting

    Occult Coronary Plaque Presence and Burden Predict Cardiovascular Events in Patients with Rheumatoid Arthritis

    George Karpouzas1, Joel Estis2, John Todd2 and Matthew Budoff3, 1Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 2Singulex, Alameda, California, Alameda, CA, 3Cardiology, Harbor-UCLA Medical Center, Torrance, CA

    Background/Purpose: Patients with Rheumatoid Arthritis (RA) experience higher cardiovascular (CV) morbidity compared to controls. Coronary computed tomography angiography (CCTA) accurately detects plaque presence, burden and…
  • Abstract Number: 138 • 2017 ACR/ARHP Annual Meeting

    Prediction of Cardiovascular Events in Rheumatoid Arthritis Patients Using a Multi-Biomarker of Disease Activity

    Fenglong Xie1, Lang Chen2, Huifeng Yun2 and Jeffrey R. Curtis3, 1Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The ACC/AHA recommends preventive strategies for patients with a high predicted risk of atherosclerotic cardiovascular disease (CVD). RA patients are at higher risk for…
  • Abstract Number: 867 • 2017 ACR/ARHP Annual Meeting

    Highly Sensitive Cardiac Troponin-I in Peripheral Blood Predicts Cardiovascular Events in Patients with Rheumatoid Arthritis

    George Karpouzas1, Joel Estis2, Long Pham3, John Todd2 and Matthew Budoff4, 1Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 2Singulex, Alameda, California, Alameda, CA, 3Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 4Cardiology, Harbor-UCLA Medical Center, Torrance, CA

    Background/Purpose: Cardiac troponins (cTn) are specific biomarkers of myocardial injury; their measurement with highly-sensitive assays and at subthreshold levels for myocardial infarction (MI) diagnosis, predicts…
  • Abstract Number: 869 • 2017 ACR/ARHP Annual Meeting

    Utility of Carotid Ultrasound Compared to Framingham Risk Score in Predicting Cardiovascular Mortality in Rheumatoid Arthritis

    Pankhuri Gupta1, Agustin Escalante2, Daniel F. Battafarano3, Jose Felix Restrepo2 and Inmaculada del Rincon2, 1Rheumatology, University of Texas Health Science Center at San Antonio, SAN ANTONIO, TX, 2Internal Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 3Medicine, San Antonio Military Medical Center, San Antonio, TX

    Background/Purpose: Rheumatoid arthritis (RA) patients have a greater risk of cardiovascular (CV) mortality compared to general population. Traditional CV risk factors may be less accurate…
  • Abstract Number: 872 • 2017 ACR/ARHP Annual Meeting

    Myocardial Abnormalities Improve in RA Patients Treated Actively – a Cardiac MRI Follow-up Study

    Riitta Koivuniemi1,2, Mia Holmström3, Antti Kuuliala2, Sari Kivistö3 and Marjatta Leirisalo-Repo1,2, 1Rheumatology, University of Helsinki, Helsinki, Finland, 2Rheumatology, Helsinki University Hospital, Helsinki, Finland, 3Radiology, HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

    Background/Purpose: Patients with RA are prone to develop myocardial dysfunction, in which chronic inflammation is suggested to play an important role. We have previously shown…
  • Abstract Number: 2358 • 2017 ACR/ARHP Annual Meeting

    Chest Pain and Angina Pectoris in Rheumatoid Arthritis: Frequency and Prediction of Cardiovascular Mortality

    Jose Felix Restrepo1, Inmaculada del Rincon1, Carlos Lorenzo1, Daniel Battafarano2 and Agustin Escalante1, 1Internal Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 2Rheumatology, San Antonio Military Medical Center (SAMMC), San Antonio, TX

    Background/Purpose:  Despite increased cardiovascular (CV) risk in rheumatoid arthritis (RA), chest pain and angina have received little attention among RA patients.  We examined the frequency…
  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology